February 2026

• Our work generating a comprehensive epigenomic atlas in clear cell renal cell carcinoma, informing kidney cancer progression and heritability, was published in Cell Reports. LINK
• Our work on cell-free DNA epigenomic profiling for the noninvasive detection and monitoring of translocation renal cell carcinoma was published in the Journal of Clinical Investigation. LINK
• We're excited to welcome Ali Hajj Ali to the team as a research fellow!
• Our research fellow Liliana Ascione presented a session at the ESMO Advanced Course on ADC age-related toxicity prediction, identification, and treatment in Zurich. LINK

January 2026

• Our work on outcomes of patients with metastatic non-clear cell RCC receiving contemporary first-line therapies, based on data from the IMDC, was published in European Urology Oncology. LINK
• Our work on soluble MAdCAM-1 as a prognostic biomarker in metastatic RCC was published in Nature Medicine. LINK

December 2025

• AUC3's expert consensus recommendations for the management of RCC and urinary tract cancers from the 2025 Advanced Urologic Cancer Consensus Conference was published in CA: A Cancer journal for clinicians. LINK
• Congratulations to our previous postdoctoral research fellows Chris Labaki and Talal Zarif on matching for their Oncology and Cardiology Fellowships at Johns Hopkins and UCLA.
• We're excited to welcome Tarek Baroud to the team as a research fellow!

November 2025

• Congratulations to our postdoctoral research fellow Pablo Moura Barrios on completing the Boston half marathon in support of Dana-Farber and the Jimmy Fund!
• Our work on targeting HIF-2 driven cachexia in kidney cancer was published in Nature Medicine. LINK

October 2025

• Our paper showing how myeloid cells mediate interferon-driven resistance to immunotherapy in RCC was published in Immunity. LINK
• Our work evaluating humoral immune responses to the second dose of a COVID-19 mRNA vaccine in cancer patients was published in Human Vaccines & Immunotherapeutics. LINK
• We're excited to welcome our new postdoctoral research fellow, Sara El Sarout, to the team!
• Congratulations to our postdoctoral research fellows Clara Steiner and Marc Machaalani for being selected for Merit Awards for their ESMO 2025 Congress abstracts!
• Our research fellows Marc Machaalani and Eddy Saad delivered Oral Presentations at the ESMO 2026 in Berlin on MAdCAM-1 as a biomarker in RCC and AI-based generation of synthetic real-world data in oncology respectively.
• Our research fellow Clara Steiner served as an Invited Discussant at the ESMO 2025 Congress for the proffered paper session on GU tumours.

September 2025

• We're excited to welcome Gaelle Nafeh and Elio Ibrahim to the team as postdoctoral research fellows!

August 2025

• Our work on overcoming c-Met-induced therapeutic resistance in renal cell carcinoma by targeting AXL was published in Cancer Letters. LINK

July 2025

• Our work on detecting squamous transformation in prostate cancer using plasma epigenomics was published in npj Precision Oncology. LINK
• Our work on the role of KIM-1 as a prognostic biomarker in metastatic renal cell carcinoma was published in European Urology focus. LINK
• Our work on the tumor-intrinsic and microenvironmental determinants of impaired antitumor immunity in chromophobe renal cell carcinoma was published in the Journal of Clinical Oncology. LINK